StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

Potassium Carbonate → 1-[4-(Pyrimidin-2-ylmethoxy)phenyl]-1,2,3,4-tetrahydroquinoxaline

HRID 1510030
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 1510030
[OH:1][C:2]1[CH:7]=[CH:6][C:5]([N:8]2[C:17]3[C:12](=[CH:13][CH:14]=[CH:15][CH:16]=3)[N:11](C(O)=O)[CH2:10][CH2:9]2)=[CH:4][CH:3]=1.Cl[CH2:22][C:23]1[N:28]=[CH:27][CH:26]=[CH:25][N:24]=1.C(=O)([O-])[O-].[K+].[K+]>CN(C)C=O>[N:24]1[CH:25]=[CH:26][CH:27]=[N:28][C:23]=1[CH2:22][O:1][C:2]1[CH:3]=[CH:4][C:5]([N:8]2[C:17]3[C:12](=[CH:13][CH:14]=[CH:15][CH:16]=3)[NH:11][CH2:10][CH2:9]2)=[CH:6][CH:7]=1
KomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

5

Edukt 3

HCID 11430Potassium Carbonate2×HCID 128773712-(Chloromethyl)pyrimidineHCID 668634364-(4-hydroxyphenyl)-3,4-dihydro-2H-quinoxaline-1-carboxylic acid

Produkt 1

HCID 668635751-[4-(Pyrimidin-2-ylmethoxy)phenyl]-1,2,3,4-tetrahydroquinoxaline

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6228Dimethylformamide
Lösungsmittel

Reaktionsbedingungen

Temperatur
100 °C

Versuchsvorschrift

0.3 g of the tert-Butyl ester of 4-(4-hydroxyphenyl)-3,4-dihydro-2H-quinoxaline-1-carboxylic acid is placed in 4.6 ml of dimethylformamide under nitrogen. 0.167 g of 2-(chloromethyl)pyrimidine and 0.508 g of potassium carbonate are added. The reaction medium is heated at 100° C. for 4 h. 0.254 g of potassium carbonate is added and heating is maintained for 1 h 30. After hydrolysis, the reaction medium is extracted with ethyl acetate until the aqueous phase has been completely extracted. The organic phases are combined, washed with a saturated aqueous sodium chloride solution, dried over magnesium sulphate and concentrated to dryness. The crude product obtained is chromatographed on silica gel, elution being carried out with a gradient of methanol in dichloromethane varying from 0% to 9/1. 0.095 g of 1-[4-(pyrimidin-2-ylmethoxy)phenyl]-1,2,3,4-tetrahydroquinoxaline is obtained.

Aufarbeitung

  1. temperatureheating
  2. temperatureis maintained for 1 h 30
  3. customAfter hydrolysis
  4. extractionthe reaction medium is extracted with ethyl acetate until the aqueous phase
  5. extractionhas been completely extracted
  6. washwashed with a saturated aqueous sodium chloride solution
  7. dry with materialdried over magnesium sulphate
  8. concentrationconcentrated to dryness
  9. customThe crude product obtained
  10. customis chromatographed on silica gel, elution

Quellen und Nachweise

ORD-Eintrag
ord-a6ae7c27a71349f1b20055c687fc62b5
Quelldatensatz
uspto-grants-2012_07
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US08211892B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenReaktionsbedingungenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion